Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
12,600
+6,400
+103% +$4.26M ﹤0.01% 1804
2026
Q1
$3.38M Buy
6,200
+2,100
+51% +$856K ﹤0.01% 2484
2025
Q4
$1.28M Hold
4,100
﹤0.01% 3375
2025
Q3
$1.11M Sell
4,100
-1,200
-23% -$275K ﹤0.01% 3396
2025
Q2
$1.17M Buy
5,300
+3,500
+194% +$631K ﹤0.01% 3123
2025
Q1
$236K Buy
+1,800
New +$251K ﹤0.01% 3861

Other funds holding AGX

David Shaw's AGX Position: Q2 2026 in Review

David Shaw reduced its Argan (AGX) stake by 70% in Q2 2026, selling an estimated $5.85M and leaving 3,710 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2859.

David Shaw first reported a position in AGX in Q2 2014 and has held it in 19 quarters since. The position peaked at $6.81M in Q1 2026. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • David Shaw held 3,710 shares of Argan worth $2.96M as of Q2 2026.
  • David Shaw sold 8,789 Argan shares in Q2 2026, an estimated $5.85M.
  • Argan made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2859 holding.
  • David Shaw first reported a position in Argan in Q2 2014 and has held it in 19 quarters since.
  • David Shaw's Argan position peaked at $6.81M in Q1 2026.
  • 562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.